Cingulate Inc. (CINGW) — Current Report

AI-Powered SEC Filing Analysis

Latest Current Report Filed: 2026-04-02

Key Insights

Cingulate Inc. (CINGW) appointed Zhanpeng 'Frederick' Jiang to its Board of Directors, effective immediately. Jiang will serve as a Class I director until the 2028 Annual Meeting of Stockholders.
Jiang was appointed to serve on the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee of the Board.
The Board determined that Jiang is independent as defined by Nasdaq listing rules. Jiang was granted a stock option and will receive annual cash retainers for his board and committee service.

Want the newest filings?

This analysis covers the filing from 2026-04-02. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-03-24

Cingulate Inc. has entered into an At-the-Market (ATM) equity offering program, allowing it to sell up to $100 million of its common stock over time.
Shareholders have approved the issuance of common stock upon conversion of Series A Convertible Preferred Stock and/or the exercise of warrants, as per the company's securities purchase agreement dated January 27, 2026.
The company has obtained shareholder approval to adjourn the special meeting if necessary to permit further solicitation and vote of proxies, though this was ultimately deemed unnecessary.

Filed: 2026-03-18

Cingulate Inc. announced positive financial results for the year ended December 31, 2025, indicating the company's operations and performance are improving.
The company received a Notice of Allowance from the USPTO for a patent on its lead asset CTx-1301, which will provide patent protection until 2042 and strengthen its intellectual property portfolio.
As an emerging growth company, Cingulate's adoption of new financial accounting standards could impact future financial reporting and investor analysis.

Filed: 2026-02-17

Cingulate Inc. (CING) issued 25,786 shares of common stock to a lender in exchange for a portion of its debt, indicating the company is actively managing its capital structure.
The company appointed Jeff Hargroves to its Board of Directors, adding an independent director with potential industry expertise to the leadership team.
Cingulate announced the successful completion of the second and final closing of its private placement, raising an additional $5.5 million in gross proceeds, for a total of approximately $12 million raised.

Filed: 2026-02-06

Cingulate Inc. issued over 360,000 shares of common stock between January 6 and February 5, 2026 to repay debt, indicating the company is actively managing its capital structure.
The company completed a $6.5 million portion of a previously announced $12 million private placement, providing additional capital to fund operations.
Cingulate is an emerging growth company, which may provide more flexibility in financial reporting and accounting standards compliance.

Filed: 2026-01-28

Cingulate Inc. raised approximately $12 million through a private placement of common stock, preferred stock, and warrants. This capital raise will provide funding to support the company's operations and development activities.
Certain officers, directors, and affiliates of Cingulate participated in the private placement, aligning their interests with those of the company and other investors.
The company has agreed to file a registration statement with the SEC to register the resale of the securities issued in the private placement, providing liquidity for the investors.

Filed: 2026-01-15

Cingulate Inc. increased the maximum aggregate offering price of shares of its common stock under the At The Market Offering Agreement from $23.5 million to $31.9 million, allowing the company to raise more capital through this program.
The company has already sold $15.1 million worth of common stock under the At The Market Offering Agreement prior to this increase.
Cingulate Inc. filed a new prospectus supplement for an additional $8.8 million of common stock that can be sold under the At The Market Offering Agreement.

Filed: 2026-01-02

Cingulate Inc. has issued a significant amount of common stock to lenders in exchange for debt repayment, indicating the company is actively managing its capital structure.
The company has issued stock at various prices ranging from $3.39 to $4.13 per share, suggesting the stock price has been volatile during this period.
The exemption from registration under Section 3(a)(9) of the Securities Act for these stock issuances indicates the company is leveraging a provision that allows for the exchange of securities without registration.

Other reports for Cingulate Inc.

Annual Report Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.